Bioprosthetic versus mechanical valves for mitral valve replacement in patients < 70 years: an updated pairwise meta-analysis.
Adham AhmedAhmed K AwadKathryn S VargheseViren S SehgalKenzy HishamJerrin GeorgeRoshan PandeyEamon VegaMia PolizziDave M MathewPublished in: General thoracic and cardiovascular surgery (2023)
The use of MMV in patients < 70 undergoing MVR is associated with lower rates of 30-day/long-term mortality compared to BPV. No significant differences were observed for risk of 30-day/long-term stroke, long-term reoperation, and long-term major bleeding. These findings support the use of MMV in younger patients, although prospective, randomized trials are still needed.
Keyphrases
- mitral valve
- end stage renal disease
- systematic review
- patients undergoing
- newly diagnosed
- ejection fraction
- chronic kidney disease
- prognostic factors
- atrial fibrillation
- aortic valve
- heart failure
- type diabetes
- aortic valve replacement
- brain injury
- patient reported
- patient reported outcomes
- transcatheter aortic valve implantation